Invention Grant
- Patent Title: C-3 alkyl and alkenyl modified betulinic acid derivatives
- Patent Title (中): C-3烷基和烯基修饰的桦木酸衍生物
-
Application No.: US14186533Application Date: 2014-02-21
-
Publication No.: US09249180B2Publication Date: 2016-02-02
- Inventor: Jacob Swidorski , Yan Chen , Sing-Yuen Sit , Nicholas A. Meanwell , Alicia Regueiro-Ren , Jie Chen , Zheng Liu , Richard A. Hartz , Li Xu
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent John F. Levis
- Main IPC: A61K31/56
- IPC: A61K31/56 ; A61K31/58 ; C07J53/00 ; C07J63/00 ; A61K31/568

Abstract:
Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, alkyl and alkenyl C-3 modified betulinic acid derivatives that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formulas I, II, III and IV:a compound of Formula I a compound of Formula II a compound of Formula III and a compound of Formula IV The compounds are useful for the treatment of HIV and AIDS.
Public/Granted literature
- US20140243298A1 C-3 ALKYL AND ALKENYL MODIFIED BETULINIC ACID DERIVATIVES Public/Granted day:2014-08-28
Information query